XF Drug Platform

Small molecule drug platform rapidly bactericidal with unique mechanisms of action

A platform of porphyrin molecules with antimicrobial activity intended for topical application for the treatment or prevention of infection

The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action.

Technology:
  • Infection prevention
  • Antimicrobial compounds

Microorganisms:
  • Bacteria

Development stage:
  • Development

Organization:
  • Company

Partnering:
  • Yes

Co-development, licensing, and outsourcing are all parts of the Destiny pharma business model.

Destiny Pharma plc is a clinical stage, virtual biotech company

N.A.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!